Control of hyperphosphatemia beyond phosphate.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 17315005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hyperphosphatemia is a prevalent condition in the dialysis population and is associated with bad outcome. Block et al. present data from a post hoc analysis indicating that sevelamer, a noncalcium-containing phosphate binder, may confer a survival benefit in incident hyperphosphatemic hemodialysis patients. This is the first intervention study in the field of mineral metabolism showing a beneficial effect on a hard end point.
Medical subject headings
- Chelating Agents
- Phosphates
- Phosphorus Metabolism Disorders
- Polyamines
- Renal Dialysis